Featured
Featured
Featured
Featured
Featured
COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC: https://www.coronavirus.gov
Get the latest research information from NIH: https://www.nih.gov/coronavirus
NIH staff guidance on coronavirus (NIH Only)
You are here
Find Funding Opportunities
Find Funding Opportunities
RSS 
CSV
XLSXNotice of Correction to Earliest Start Date for PAR-20-240 "NIH Neuroscience Development for Advancing the Careers of a Diverse Research Workforce (R25 Clinical Trial Not Allowed)"
Funding Opportunity Purpose
The purpose of this notice is to inform applicants of a correction to the Earliest Start Date for PAR-20-240 "NIH Neuroscience Development for Advancing the Careers of a Diverse Research Workforce (R25 Clinical Trial Not Allowed)". The Earliest Start Dates have been corrected to read: November 2021, November 2022 and November 2023.
Notice of Extension to PA-18-400, "Research on Autism Spectrum Disorders (R21-Clinical Trial Optional)"
Funding Opportunity Purpose
This Notice extends PA-18-400, "Research on Autism Spectrum Disorders (R21-Clinical Trial Optional)" by one additional receipt date.
Notice of Extension to PA-18-401, "Research on Autism Spectrum Disorders (R01-Clinical Trial Optional)"
Funding Opportunity Purpose
This Notice extends PA-18-401, "Research on Autism Spectrum Disorders (R01 Clinical Trial Optional)" by one additional receipt date.
Notice of Change to Key Dates for PAS-18-483 "Promoting Research in Basic Neuroscience (R01 Clinical Trial Not Allowed)"
Funding Opportunity Purpose
The purpose of this notice is to inform interested applicants of a change to the Key Dates for PAS-18-483 "Promoting Research in Basic Neuroscience (R01 Clinical Trial Not Allowed)" (changes shown below in italics). This Funding Opportunity Announcement has been extended by one additional council round. The dates have been modified to add the following New Application Due Date: February 5, 2021, Revision, Resubmission and Renewal date: March 5, 2021, and AIDS application due date of May 8, 2021.
Notice of Special Interest to Encourage Eligible NIH HEAL Initiative Awardees to Apply for PA-20-222: Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)
Funding Opportunity Purpose
This Notice encourages eligible awardees in the HEAL Initiative community to apply for administrative supplements in response to PA-20-222, Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed). The NIH has a strong interest in the diversity of the NIH-funded workforce (see NOT-OD-20-031) and encourages institutions to diversify their populations by enhancing the participation of individuals from groups identified as underrepresented in the biomedical, clinical, behavioral, and social sciences.
Change of the Award Project Period for PAR-18-950 and PAR-18-951 Opportunities for Collaborative Research at the NIH Clinical Center (X02 and U01)
Funding Opportunity Purpose
The purpose of this Notice is to clarify the language in these Funding Opportunity Announcements (FOAs) regarding the length of the Award Project Period.
Notice of Change to PAR-19-315 "Discovery of Biomarkers and Biomarker Signatures for Neurological and Neuromuscular Disorders (R61/R33 Clinical Trial Optional)"
Funding Opportunity Purpose
The purpose of this notice is to inform applicants of a change to the Key Dates for PAR-19-315 "Discovery of Biomarkers and Biomarker Signatures for Neurological and Neuromuscular Disorders (R61/R33 Clinical Trial Optional)". Specifically, the remaining 3 dates have changed to February 22, 2021, June 22, 2021, and February 22, 2022
Collaborative Research in Computational Neuroscience (CRCNS) NSF Innovative Approaches to Science and Engineering Research on Brain Function
Funding Opportunity Purpose
This Notice announces the reissue of a joint initiative, Collaborative Research in Computational Neuroscience (CRCNS), among six National Science Foundation (NSF) Directorates and Offices (DOs), and nine participating National Institutes of Health (NIH).
Notice of Temporary Extension of Eligibility for the BRAIN Initiative Diversity K99/R00 Career Transition Award During the COVID-19 Pandemic
Funding Opportunity Purpose
The purpose of this Notice is to inform the extramural community that as a result of disruptions caused by the COVID-19 pandemic, the BRAIN Initiative will be providing up to a two-receipt cycle extension (roughly eight additional months) of eligibility for prospective applicants meeting the requirements for submission of an application to the BRAIN Initiative Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00) through the February/March 2021 due dates.
Notice of Change to Key Dates for RFA-NS-19-001 "BRAIN Initiative: Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (U01 Clinical Trial Required)"
Funding Opportunity Purpose
The purpose of this notice is to inform interested applicants of a change to the Key Dates and the specific research requirements for RFA-NS-19-001 "BRAIN Initiative: Research Opportunities Using Invasive Neural Recording and Stimulating Technologies in the Human Brain (U01 Clinical Trial Required)". The dates have been modified to add a new application due date of October 29, 2021. See changes below inbold italics.
